|Day Low/High||106.71 / 108.16|
|52 Wk Low/High||65.97 / 108.57|
The recent bid by Mylan to acquire Perrigo offers the latest example of pharma companies that have been seeking growth opportunities.
Ikaria, which focuses on therapies for critically ill infants, is privately owned by a group led by Madison Dearborn Partners. Buyer Mallinckrodt specializes in diagnostic radiology and pain management.
After a robust year of mega-deals in 2014, mid-size device makers are expected to seek partners, fueling even further consolidation.
Medtronic's $49.9 billion acquisition of Covidien -- the largest tax inversion deal ever -- will leave shareholders with a big tax bill, while Medtronic may pay little or no taxes.
Covidien plc (NYSE: COV) today announced, for purposes of the Irish Takeover Rules, that the scheme of arrangement under which Medtronic acquired Covidien under a new holding company incorporated in Ireland to be named...
Stryker must significantly outperform for all of 2015 just to meet expectations. That's a tall order.
TheStreet highlights 3 stocks pushing the health services industry lower today.
Trade-Ideas LLC identified Covidien (COV) as a new lifetime high candidate
Here's a look at 10 stocks that Paulson & Co. bought in the most recently reported quarter.
Covidien is sponsoring the Retreat & Refresh Stroke Camp (Stroke Camp), a three-day retreat for stroke survivors, caregivers and family members dedicated to helping these often forgotten victims of stroke relax...
Covidien (COV) shares are climbing after the company reported its first quarter earnings results.
Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2015.
Shares of Covidien (COV) closed higher Wednesday ahead of the healthcare company's first-quarter earnings report before the market open Thursday.